{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:47:37Z","timestamp":1790131657153,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["41977372"],"award-info":[{"award-number":["41977372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["20231120193941001"],"award-info":[{"award-number":["20231120193941001"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["20231121155815002"],"award-info":[{"award-number":["20231121155815002"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["20231120124911001"],"award-info":[{"award-number":["20231120124911001"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012760"],"award-info":[{"award-number":["2024A1515012760"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Breast cancer (BC) is the most common tumor worldwide and it has been recognized that up to one third of BC patients have co-existing diabetes mellitus (DM) (BC-DM). Although many observational studies have indicated an association between DM and BC, the causal relationship of DM and BC prognosis remained uncertain and the molecular mechanisms underlying BC-DM are largely unclear. In this study, we used causal inference methods, including g-computation (GC), inverse probability of treatment weighting (IPTW), targeted maximum likelihood estimation (TMLE), and TMLE-super learner (TMLE-SL), to comprehensively analyze the association of DM with BC mortality in a cohort of 3386 BC patients. We found that the adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for 5-year mortality in BC-DM patients were 1.926 (1.082, 2.943), 2.268 (1.063, 3.974), 1.917 (1.091, 2.953), and 2.113 (1.365, 3.270), respectively. Further transcriptomic and qPCR analyses identified that FIBCD1 was highly expressed in BC-DM tumor tissues and in BC cells under hyperglycemia conditions. Functionally, upregulation of FIBCD1 promoted proliferation, migration, and invasion capacities of BC cells in a glucose level-dependent manner. While knockdown of FIBCD1 suppressed BC tumor growth in diabetic mice. Integrated RNA-seq and Ribo-seq analysis revealed that MCM5 was a target of FIBCD1. Mechanistically, hyperglycemia-activated FIBCD1 promoted MCM5 expression to induce S-phase cell cycle arrest by upregulating histone H3K27ac levels in MCM5 promoter via the PDH-acetyl-CoA axis. Our findings provide new evidence that co-existing DM has a causal effect on overall mortality in BC-DM patients. Targeting FIBCD1 may be a promising therapy for BC-DM.<\/jats:p>","DOI":"10.1038\/s41419-025-07849-w","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T14:18:37Z","timestamp":1753193917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes is causally associated with increased breast cancer mortality by inducing FIBCD1 to activate MCM5-mediated cell cycle arrest via modulating H3K27ac"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-9732","authenticated-orcid":false,"given":"Binbin","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-6731","authenticated-orcid":false,"given":"Kaiping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2643-6278","authenticated-orcid":false,"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-4134","authenticated-orcid":false,"given":"Rihong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"7849_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7849_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885\u201392.","journal-title":"JAMA"},{"key":"7849_CR3","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1200\/JCO.2008.17.5935","volume":"27","author":"TP Srokowski","year":"2009","unstructured":"Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009;27:2170\u20136.","journal-title":"J Clin Oncol"},{"key":"7849_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.294.14.1765","volume":"294","author":"CM Tammemagi","year":"2005","unstructured":"Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294:1765\u201372.","journal-title":"JAMA"},{"key":"7849_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/1055-9965.EPI-17-0439","volume":"27","author":"S Shao","year":"2018","unstructured":"Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, et al. Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System. Cancer Epidemiol Biomark Prev. 2018;27:50\u201357.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7849_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-018-5025-2","volume":"173","author":"G Maskarinec","year":"2019","unstructured":"Maskarinec G, Shvetsov YB, Conroy SM, Haiman CA, Setiawan VW, Le Marchand L. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort. Breast Cancer Res Treat. 2019;173:637\u201345.","journal-title":"Breast Cancer Res Treat"},{"key":"7849_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/bjc.2012.414","volume":"107","author":"P Boyle","year":"2012","unstructured":"Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107:1608\u201317.","journal-title":"Br J Cancer"},{"key":"7849_CR8","first-page":"1061","volume":"12","author":"S Liao","year":"2011","unstructured":"Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev. 2011;12:1061\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"7849_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/ERC-12-0242","volume":"19","author":"PJ Hardefeldt","year":"2012","unstructured":"Hardefeldt PJ, Edirimanne S, Eslick GD. Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cance r. 2012;19:793\u2013803.","journal-title":"Endocr Relat Cance r"},{"key":"7849_CR10","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"BB Barone","year":"2008","unstructured":"Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754\u201364.","journal-title":"JAMA"},{"key":"7849_CR11","doi-asserted-by":"publisher","first-page":"e5602","DOI":"10.1097\/MD.0000000000005602","volume":"95","author":"XB Zhao","year":"2016","unstructured":"Zhao XB, Ren GS. Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltim). 2016;95:e5602.","journal-title":"Medicine (Baltim)"},{"key":"7849_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/ans.12877","volume":"85","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Zhang X, Gu C, Xia J. Influence of diabetes mellitus on mortality in breast cancer patients. ANZ J Surg. 2015;85:972\u20138.","journal-title":"ANZ J Surg"},{"key":"7849_CR13","first-page":"271","volume":"33","author":"L Fern\u00e1ndez-Arce","year":"2022","unstructured":"Fern\u00e1ndez-Arce L, Robles-Rodr\u00edguez N, Fern\u00e1ndez-Feito A, Llaneza-Folgueras A, Encinas-Mu\u00f1iz AI, Lana A. Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer. Cancer Causes Control. 2022;33:271\u20138.","journal-title":"Cancer Causes Control"},{"key":"7849_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-005-0324-9","volume":"91","author":"W Du","year":"2005","unstructured":"Du W, Simon MS. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005;91:243\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"7849_CR15","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/annonc\/mdt224","volume":"24","author":"S Jiralerspong","year":"2013","unstructured":"Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol. 2013;24:2506\u201314.","journal-title":"Ann Oncol"},{"key":"7849_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10549-014-3146-9","volume":"148","author":"J Luo","year":"2014","unstructured":"Luo J, Virnig B, Hendryx M, Wen S, Chelebowski R, Chen C, et al. Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat. 2014;148:153\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"7849_CR17","first-page":"1065","volume":"26","author":"GS Calip","year":"2015","unstructured":"Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes Control. 2015;26:1065\u201377.","journal-title":"Cancer Causes Control"},{"key":"7849_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.annonc.2020.12.014","volume":"32","author":"AE Lohmann","year":"2021","unstructured":"Lohmann AE, Goodwin PJ. Diabetes, metformin and breast cancer: a tangled web. Ann Oncol. 2021;32:285\u20136.","journal-title":"Ann Oncol"},{"key":"7849_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-publhealth-040218-044048","volume":"40","author":"MA Bind","year":"2019","unstructured":"Bind MA. Causal Modeling in Environmental Health. Annu Rev Public Health. 2019;40:23\u201343.","journal-title":"Annu Rev Public Health"},{"key":"7849_CR20","doi-asserted-by":"publisher","first-page":"381.e381","DOI":"10.1016\/j.ajog.2018.12.030","volume":"220","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, et al. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model. Am J Obstet Gynecol. 2019;220:381.e381\u2013381.e314.","journal-title":"Am J Obstet Gynecol"},{"key":"7849_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymeth.2022.07.001","volume":"205","author":"J Peng","year":"2022","unstructured":"Peng J, Lu Y, Chen L, Qiu K, Chen F, Liu J, et al. The prognostic value of machine learning techniques versus cox regression model for head and neck cancer. Methods. 2022;205:123\u201332.","journal-title":"Methods"},{"key":"7849_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1289\/ehp.1409671","volume":"124","author":"Y Wang","year":"2016","unstructured":"Wang Y, Kloog I, Coull BA, Kosheleva A, Zanobetti A, Schwartz JD. Estimating Causal Effects of Long-Term PM2.5 Exposure on Mortality in New Jersey. Environ Health Perspect. 2016;124:1182\u20138.","journal-title":"Environ Health Perspect"},{"key":"7849_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/aje\/kww165","volume":"185","author":"MS Schuler","year":"2017","unstructured":"Schuler MS, Rose S. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies. Am J Epidemiol. 2017;185:65\u201373.","journal-title":"Am J Epidemiol"},{"key":"7849_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.annonc.2023.11.013","volume":"35","author":"JM Piulats","year":"2024","unstructured":"Piulats JM, Watkins C, Costa-Garc\u00eda M, Del Carpio L, Piperno-Neumann S, Rutkowski P, et al. Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis. Ann Oncol. 2024;35:317\u201326.","journal-title":"Ann Oncol"},{"key":"7849_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/resp.14001","volume":"26","author":"M Rossides","year":"2021","unstructured":"Rossides M, Kullberg S, Di Giuseppe D, Eklund A, Grunewald J, Askling J, et al. Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective \u2018target trial\u2019 emulated with Swedish real-world data. Respirology. 2021;26:452\u201360.","journal-title":"Respirology"},{"key":"7849_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04466-x","volume":"27","author":"LF Reyes","year":"2023","unstructured":"Reyes LF, Garcia E, Ib\u00e1\u00f1ez-Prada ED, Serrano-Mayorga CC, Fuentes YV, Rodr\u00edguez A, et al. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis. Crit Care. 2023;27:212.","journal-title":"Crit Care"},{"key":"7849_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1634\/theoncologist.2011-0412","volume":"17","author":"WW Chen","year":"2012","unstructured":"Chen WW, Shao YY, Shau WY, Lin ZZ, Lu YS, Chen HM, et al. The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist. 2012;17:485\u201391.","journal-title":"Oncologist"},{"key":"7849_CR28","first-page":"103","volume":"34","author":"C Lao","year":"2023","unstructured":"Lao C, Gurney J, Stanley J, Krebs J, Meredith I, Campbell I, et al. Association of diabetes and breast cancer characteristics at diagnosis. Cancer Causes Control. 2023;34:103\u201311.","journal-title":"Cancer Causes Control"},{"key":"7849_CR29","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3324\/haematol.2019.239970","volume":"106","author":"I Boussaid","year":"2021","unstructured":"Boussaid I, Le Goff S, Floquet C, Gautier EF, Raimbault A, Viailly PJ, et al. Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells. Haematologica. 2021;106:746\u201358.","journal-title":"Haematologica"},{"key":"7849_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","volume":"173","author":"RK Khajuria","year":"2018","unstructured":"Khajuria RK, Munschauer M, Ulirsch JC, Fiorini C, Ludwig LS, McFarland SK, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018;173:90\u2013103.e119.","journal-title":"Cell"},{"key":"7849_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218\u201323.","journal-title":"Science"},{"key":"7849_CR32","doi-asserted-by":"publisher","first-page":"105552","DOI":"10.1016\/j.jbc.2023.105552","volume":"300","author":"HM Williams","year":"2024","unstructured":"Williams HM, Moeller JB, Burns I, Schlosser A, Sorensen GL, Greenhough TJ, et al. Crystal structures of human immune protein FIBCD1 suggest an extended binding site compatible with recognition of pathogen-associated carbohydrate motifs. J Biol Chem. 2024;300:105552.","journal-title":"J Biol Chem"},{"key":"7849_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2014.04.046","volume":"158","author":"G Sutendra","year":"2014","unstructured":"Sutendra G, Kinnaird A, Dromparis P, Paulin R, Stenson TH, Haromy A, et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell. 2014;158:84\u201397.","journal-title":"Cell"},{"key":"7849_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/jn.00200.2021","volume":"127","author":"V Jakkamsetti","year":"2022","unstructured":"Jakkamsetti V, Ma Q, Pascual JM. A subset of synaptic transmission events is coupled to acetyl coenzyme A production. J Neurophysiol. 2022;127:623\u201336.","journal-title":"J Neurophysiol"},{"key":"7849_CR35","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661\u201379.","journal-title":"Stat Med"},{"key":"7849_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/aje\/kwq472","volume":"173","author":"JM Snowden","year":"2011","unstructured":"Snowden JM, Rose S, Mortimer KM. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am J Epidemiol. 2011;173:731\u20138.","journal-title":"Am J Epidemiol"},{"key":"7849_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2288-13-152","volume":"13","author":"P Royston","year":"2013","unstructured":"Royston P, Parmar MK. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med Res Methodol. 2013;13:152.","journal-title":"BMC Med Res Methodol"},{"key":"7849_CR38","first-page":"795","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Sun M, Liu J, Liu Y, Jiang C, Zhu H, et al. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma. Oncol Lett. 2020;19:795\u2013804.","journal-title":"Oncol Lett"},{"key":"7849_CR39","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1074\/jbc.M113.520577","volume":"289","author":"AK Shrive","year":"2014","unstructured":"Shrive AK, Moeller JB, Burns I, Paterson JM, Shaw AJ, Schlosser A, et al. Crystal structure of the tetrameric fibrinogen-like recognition domain of fibrinogen C domain containing 1 (FIBCD1) protein. J Biol Chem. 2014;289:2880\u20137.","journal-title":"J Biol Chem"},{"key":"7849_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/ajcp\/aqy013","volume":"149","author":"C Jiang","year":"2018","unstructured":"Jiang C, Zhu J, Zhou P, Zhu H, Wang W, Jin Q, et al. Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer. Am J Clin Pathol. 2018;149:474\u201383.","journal-title":"Am J Clin Pathol"},{"key":"7849_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cncr.31837","volume":"125","author":"G Simonetti","year":"2019","unstructured":"Simonetti G, Padella A, do Valle IF, Fontana MC, Fonzi E, Bruno S, et al. Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery. Cancer. 2019;125:712\u201325.","journal-title":"Cancer"},{"key":"7849_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.urolonc.2022.03.001","volume":"40","author":"G Sharma","year":"2022","unstructured":"Sharma G, Sharma A, Krishna M, Ahluwalia P, Gautam G. Diagnostic performance of minichromosome maintenance 5 (MCM5) in bladder cancer: A systematic review and meta-analysis. Urol Oncol. 2022;40:235\u201342.","journal-title":"Urol Oncol"},{"key":"7849_CR43","doi-asserted-by":"publisher","first-page":"152072","DOI":"10.1016\/j.acthis.2023.152072","volume":"125","author":"J Mao","year":"2023","unstructured":"Mao J, Shen J, Lu X, Cai Y, Tao R, Deng Y, et al. MCM5 is an oncogene of colon adenocarcinoma and promotes progression through cell cycle control. Acta Histochem. 2023;125:152072.","journal-title":"Acta Histochem"},{"key":"7849_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopha.2017.12.006","volume":"98","author":"D Wang","year":"2018","unstructured":"Wang D, Li Q, Li Y, Wang H. The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis. Biomed Pharmacother. 2018;98:165\u201372.","journal-title":"Biomed Pharmacother"},{"key":"7849_CR45","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1186\/s12885-020-07468-y","volume":"20","author":"J Stockley","year":"2020","unstructured":"Stockley J, Akhand R, Kennedy A, Nyberg C, Crosbie EJ, Edmondson RJ. Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours. BMC Cancer. 2020;20:1000.","journal-title":"BMC Cancer"},{"key":"7849_CR46","doi-asserted-by":"publisher","first-page":"669132","DOI":"10.3389\/fcell.2021.669132","volume":"9","author":"LL Zhang","year":"2021","unstructured":"Zhang LL, Li Q, Zhong DS, Zhang WJ, Sun XJ, Zhu Y. MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer. Front Cell Dev Biol. 2021;9:669132.","journal-title":"Front Cell Dev Biol"},{"key":"7849_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12253-018-0433-5","volume":"24","author":"P Guo","year":"2018","unstructured":"Guo P, Chen W, Li H, Li M, Li L. The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications. Pathol Oncol Res. 2018;24:807\u201313.","journal-title":"Pathol Oncol Res"},{"key":"7849_CR48","doi-asserted-by":"publisher","first-page":"112583","DOI":"10.1016\/j.celrep.2023.112583","volume":"42","author":"E Mocholi","year":"2023","unstructured":"Mocholi E, Russo L, Gopal K, Ramstead AG, Hochrein SM, Vos HR, et al. Pyruvate metabolism controls chromatin remodeling during CD4(+) T cell activation. Cell Rep. 2023;42:112583.","journal-title":"Cell Rep."},{"key":"7849_CR49","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"key":"7849_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1200\/JCO.2010.29.3183","volume":"29","author":"K Erickson","year":"2011","unstructured":"Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, et al. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol. 2011;29:54\u201360.","journal-title":"J Clin Oncol"},{"key":"7849_CR51","doi-asserted-by":"publisher","first-page":"114890","DOI":"10.1016\/j.intimp.2025.114890","volume":"159","author":"Y Shan","year":"2025","unstructured":"Shan Y, Zhao J, Wei K, Jiang P, Shi Y, Chang C, et al. Multi-target RNA interference: A disruptive next-generation strategy for precision treatment of rheumatoid arthritis. Int Immunopharmacol. 2025;159:114890.","journal-title":"Int Immunopharmacol"},{"key":"7849_CR52","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"7849_CR53","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Sec. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2016; 39 Suppl 1:S13-22.","DOI":"10.2337\/dc16-S005"},{"key":"7849_CR54","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/sim.7628","volume":"37","author":"MA Luque-Fernandez","year":"2018","unstructured":"Luque-Fernandez MA, Schomaker M, Rachet B, Schnitzer ME. Targeted maximum likelihood estimation for a binary treatment: A tutorial. Stat Med. 2018;37:2530\u201346.","journal-title":"Stat Med"},{"key":"7849_CR55","doi-asserted-by":"crossref","first-page":"Article25","DOI":"10.2202\/1544-6115.1309","volume":"6","author":"MJ van der Laan","year":"2007","unstructured":"van der Laan MJ, Polley EC, Hubbard AE. Super learner. Stat Appl Genet Mol Biol. 2007;6:Article25.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"7849_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12874-023-01835-6","volume":"23","author":"J Ren","year":"2023","unstructured":"Ren J, Cislo P, Cappelleri JC, Hlavacek P, DiBonaventura M. Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study. BMC Med Res Methodol. 2023;23:18.","journal-title":"BMC Med Res Methodol"},{"key":"7849_CR57","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/bjc.2017.335","volume":"117","author":"SB Nandy","year":"2017","unstructured":"Nandy SB, Orozco A, Lopez-Valdez R, Roberts R, Subramani R, Arumugam A, et al. Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis. Br J Cancer. 2017;117:1665\u201375.","journal-title":"Br J Cancer"},{"key":"7849_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13058-024-01870-1","volume":"26","author":"Y Huang","year":"2024","unstructured":"Huang Y, Chen C, Liu Y, Tan B, Xiang Q, Chen Q, et al. Downregulation of tRF-Cys-GCA-029 by hyperglycemia promotes tumorigenesis and glycolysis of diabetic breast cancer through upregulating PRKCG translation. Breast Cancer Res. 2024;26:117.","journal-title":"Breast Cancer Res"},{"key":"7849_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-022-01270-y","volume":"15","author":"W Yang","year":"2022","unstructured":"Yang W, Gao K, Qian Y, Huang Y, Xiang Q, Chen C, et al. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1\/MED29 and ELK4\/MED29 axes. J Hematol Oncol. 2022;15:53.","journal-title":"J Hematol Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07849-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:12:06Z","timestamp":1757272326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07849-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7849"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07849-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human sample collection and cohort study were approved by the Clinical Research Ethics Committee of Shenzhen University (Approved No. 2019015). Animal experiments were performed in accordance with the guidelines approved by the Institutional Animal Care and Use Committee of Shenzhen University Medical School (Approved No. IACUC-202300060).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"546"}}